Ambulero
0 followers
‌
Ambulero is a cell and gene therapy spin-out of the University of Miami focused on advancing new therapies to fight vascular disease. A platform company that can deliver the adhesion molecule E-selectin using different cell and synthetic vector technologies.
Industries
Headquarters
Employees
Links
Org chart
Robert L. Buchanan
Chief Executive Officer
Robert L. Buchanan
Collapse
Carlton Anderson
Chief Operations Officer
Omaida Caridad Velazquez
Chief Medical Officer
Zhao-Jun Liu
Chief Scientific Officer
Khemraj Hirani
Chief Regulatory Officer
Randy Berholtz
Co-founder And Chairman Of The Board
